Not even any apologies for their woeful underperformance,and also hinting that better figures after approvals are somewhat dependent on timelines of competitors products reaching the market.Unbelievable and very hard to stay solid .
- Forums
- ASX - By Stock
- MYX
- Ann: Annual Report to shareholders
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

Ann: Annual Report to shareholders, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
1 | 905 | 5.060 |
1 | 1000 | 5.050 |
3 | 4055 | 5.040 |
1 | 600 | 5.030 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.170 | 905 | 1 |
5.180 | 2396 | 2 |
5.190 | 5905 | 2 |
5.200 | 157 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online